Physician

Badr Jandali, MD

According to 2025 Medicare claims, Badr Jandali, MD (NPI: 1891083382) practices internal medicine in the St. Joseph, MO-KS market, with the plurality of this provider's patient population coming from Buchanan, MO. This provider's primary affiliated billing organization is HEARTLAND REGIONAL MEDICAL CENTER (NPI: 1538200357; TIN: 440545289) and primary practice location at 64506-3488.

Jandali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 702 traditional Medicare patients, billed 2,445 HCPCS/CPT codes, and received $148,316 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,670 prescription claims across 329 beneficiaries totaling $972,074 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 1,253 claims. Open Payments data shows 10 records totaling $1,463. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $76,584 and ending at $148,316. Concurrently, Part D prescription costs have risen steadily, from $10,274 to $972,074. For DME billing, reported payments rose steadily, from $3,758 to $88,678.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	286	827	$76,584
2016	413	1,524	$130,189
2017	467	1,559	$195,310
2018	146	507	$48,380
2019	N/R	N/R	N/R
2020	23	41	$3,351
2021	168	659	$47,112
2022	456	1,824	$124,194
2023	522	1,956	$137,158
2024	702	2,445	$148,316

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	118	285	$10,274
2016	168	377	$19,957
2017	195	369	$18,848
2018	78	164	$7,592
2019	N/R	11	$2,554
2020	15	61	$19,787
2021	48	89	$29,973
2022	172	541	$224,258
2023	211	872	$515,710
2024	329	1,670	$972,074

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	79	$3,430
2016	N/R	116	$4,225
2017	N/R	15	$56
2018	N/R	58	$287
2019	N/R	N/R	N/R
2020	N/R	12	$316
2021	N/R	17	$113
2022	30	376	$20,690
2023	101	694	$85,278
2024	208	1,253	$131,852

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	373	539	$67
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	138	375	$58
94726	Test to determine lung volumes using sensors	139	151	$8
94060	Test to measure expiratory airflow and volume changes before and after medication administration	144	159	$7
94729	Test to examine how well the lungs exchange gases	144	159	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	20	600	$261,578
Fasenra Pen	Benralizumab	19	868	$113,249
Spiriva Respimat	Tiotropium Bromide	95	4,770	$83,952
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	67	4,050	$65,321
Nucala	Mepolizumab	12	336	$51,403

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	43	$35,801
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	27	$25,504
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	43	301	$24,621
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	26	$23,410
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	11	62	$4,539

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$1,463	Pulmonx Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Badr Jandali, MD?

Tedicare shows public-source Medicare data for Badr Jandali, MD (NPI 1891083382), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Badr Jandali, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Badr Jandali, MD?

Badr Jandali, MD is linked to HEARTLAND REGIONAL MEDICAL CENTER (billing NPI 1538200357) in the available physician profile data.

Does Badr Jandali, MD have Open Payments data?

Badr Jandali, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.